Synthesis and Biological Assessment of Cyanopyridine‐Based 1,3,4‐Oxadiazole Derivatives: Anticancer Potential, Antioxidant Activity, Molecular Docking, and DFT Calculations
Journal of Biochemical and Molecular Toxicology · 2025-06 · 39 (6)
DOI: 10.1002/jbt.70346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 17.06.2025. Verfasst von Zineddine Zebbiche und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Synthesis of Molecules with Biological Interest, Mentouri Constantine University, Constantine, Algeria. Hauptthemen laut MEDLINE: Oxadiazoles, Molecular Docking Simulation, Antineoplastic Agents, Antioxidants. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A series of six novel cyanopyridine derivatives bearing a 1,3,4‐oxadiazole ring have been synthesized and characterized by FTIR, 13 C NMR, 1 H NMR, and elemental analysis. DFT calculations were carried out to determine their molecular geometries, electronic properties, and chemical reactivity. Their cytotoxicity has been evaluated against MCF‐7 and CaCo‐2 human cancer cell lines using the MTT assay. Most compounds displayed poor cytotoxic activity against the MCF‐7 cell line except for compound 4e , which showed potent activity with IC 50 = 8.352 µM. However, the CaCo‐2 cell line was highly sensitive toward most tested compounds with an IC 50 range from 2.612 µM to 8.394 µM except for compound 4 d . Molecular docking studies targeting human topoisomerase‐IIβ revealed that all compounds exhibited excellent binding affinity within the enzyme's active site, with binding energies ranging from −7.33 to −8.28 kcal/mol. These findings suggest a potential anticancer mechanism underlying the observed cytotoxic activities. All tested compounds revealed low antioxidant activity in the DPPH assay. However, compounds 5b and 5 d presented moderate metal chelating activity. These findings underscore the potential anticancer properties of the synthesized cyanopyridine derivatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Synthesis of Molecules with Biological Interest, Mentouri Constantine University, Constantine, Algeria.
- Physiology Department, Faculty of Medicine, İnönü University, Malatya, Turkey.
- Basic Pharmaceutical Sciences Department, Faculty of Pharmacy, İnönü University, Malatya, Turkey.
- Department of Chemistry, Faculty of Arts and Sciences, İnönü University, Malatya, Turkey.
ORCID-Profile: Zineddine Zebbiche, Güldeniz Şekerci, Suat Tekin, Hasan Küçükbay
Zitieren
APA
Zebbiche, Z., Şekerci, G., Houssem, B., Küçükbay, F., Tekin, S., Küçükbay, H., & Boumoud, B. (2025). Synthesis and Biological Assessment of Cyanopyridine‐Based 1,3,4‐Oxadiazole Derivatives: Anticancer Potential, Antioxidant Activity, Molecular Docking, and DFT Calculations. Journal of Biochemical and Molecular Toxicology, 39(6). https://doi.org/10.1002/jbt.70346
Vancouver
Zebbiche Z, Şekerci G, Houssem B, Küçükbay F, Tekin S, Küçükbay H, et al. Synthesis and Biological Assessment of Cyanopyridine‐Based 1,3,4‐Oxadiazole Derivatives: Anticancer Potential, Antioxidant Activity, Molecular Docking, and DFT Calculations. Journal of Biochemical and Molecular Toxicology. 2025;39(6). doi:10.1002/jbt.70346
BibTeX
@article{Zebbiche2025,
author = {Zebbiche, Zineddine and Şekerci, Güldeniz and Houssem, Boulebd and Küçükbay, Fatümetüzzehra and Tekin, Suat and Küçükbay, Hasan and Boumoud, Boudjemaa},
title = {Synthesis and Biological Assessment of Cyanopyridine‐Based 1,3,4‐Oxadiazole Derivatives: Anticancer Potential, Antioxidant Activity, Molecular Docking, and DFT Calculations},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
volume = {39},
number = {6},
doi = {10.1002/jbt.70346}
}
EUVIMED